DPS Parmar explains why patent descriptions can be crucial for patent grant and enablement with reference to India and US cases Amgen v Sanofi (2021) and Juno Therapeutics v Kite Pharma (2021).
Link: https://patentlawyermagazine.com/wp-content/uploads/2022/02/TPL_Issue-58_interactive.pdf (Pdf 39 Pages)
For further information, please contact:
DPS Parmar, Head of the IPAB practice group, LexOrbis
mail@lexorbis.com
